Mild atopic dermatitis is characterized by increase in non-staphylococcus pathobionts and loss of specific species/Experiment 1

From BugSigDB


Reviewed Marked as Reviewed by Svetlana up on 2024-11-6

Curated date: 2024/10/12

Curator: Joiejoie

Revision editor(s): Joiejoie, Aleru Divine

Subjects

Location of subjects
Belgium
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Skin of body Entire integument,Entire skin,Integument,Integumental organ,Pelt,Skin,Skin organ,Skin of body,skin of body
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Dermatitis inflammation of skin,inflammation of the skin,inflammation of zone of skin,inflammatory skin disease,skin inflammation,zone of skin inflammation,Dermatitis,dermatitis
Group 0 name Corresponds to the control (unexposed) group for case-control studies
healthy controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
mild atopic dermatitis (AD)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Participants diagnosed with mild atopic dermatitis (AD). This group specifically includes individuals who exhibit mild lesions characterized by limited symptoms.
Group 0 sample size Number of subjects in the control (unexposed) group
49
Group 1 sample size Number of subjects in the case (exposed) group
28
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
N/A

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
log transformation
Statistical test
MaAsLin2
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes


Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2024-11-6

Curated date: 2024/10/12

Curator: Joiejoie

Revision editor(s): Joiejoie, Aleru Divine

Source: Figure 3a

Description: Differential abundance analysis for mild AD patients compared to healthy participants using Maaslin2

Abundance in Group 1: increased abundance in mild atopic dermatitis (AD)

NCBI Quality ControlLinks
Bifidobacterium pullorum
Burkholderia
Burkholderia sp.
Haemophilus parainfluenzae
Mycobacterium ostraviense
Paeniglutamicibacter antarcticus
Paraburkholderia
Pedobacter panaciterrae
Photobacterium chitinilyticum
Pyramidobacter sp.
Sodaliphilus pleomorphus
Staphylococcus aureus
Staphylococcus epidermidis
Stenotrophomonas maltophilia
Streptococcus oralis
Streptomyces
Streptomyces fumigatiscleroticus
Streptosporangiaceae
Streptosporangium violaceochromogenes
Chroococcus hegewaldiChroococcus hegewaldi
Thiorhodococcus violaceaThiorhodococcus violacea
Bacteroidales bacterium Barb7
Streptomyces malachitofuscus
Streptomyces griseoincarnatus
Crocosphaera chwakensis
Streptomyces kurssanovii
Limosilactobacillus alvi
Spirillospora cremeaSpirillospora cremea
Aestuariibaculum marinum
Flavobacterium hauense
Caproicibacter sp.
Mariprofundus erugo
Mycobacterium sp.
Chromatium weissei
Butyricimonas sp.
IAFGDP01 spIAFGDP01 sp
Staphylococcus schweitzeri
Paraburkholderia sp.

Revision editor(s): Joiejoie, Aleru Divine

Signature 2

Reviewed Marked as Reviewed by Svetlana up on 2024-11-6

Curated date: 2024/10/12

Curator: Joiejoie

Revision editor(s): Joiejoie, Aleru Divine

Source: Figure 3a

Description: Differential abundance analysis for mild AD patients compared to healthy participants using Maaslin2

Abundance in Group 1: decreased abundance in mild atopic dermatitis (AD)

NCBI Quality ControlLinks
Acinetobacter
Acinetobacter lwoffii
Alphaproteobacteria
Bacteroidia
Bradyrhizobium
Brevundimonas
Epilithonimonas hominis
Hyphomicrobiales
Kaistella
Kaistella haifensis
Kocuria
Kocuria palustris
Microbacteriaceae
Micrococcaceae
Micrococcus endophyticus
Moraxella
Moraxella osloensis
Moraxella sp.
Moraxellaceae
Neisseria cinerea
Nocardioides
Paracoccaceae
Paracoccus
Pseudomonadales
Rothia
Sphingomonas
Sphingopyxis
Xanthobacteraceae
Agrobacterium pusense
Micrococcus cohnii
Kocuria salsicia
Bifidobacterium vaginaleBifidobacterium vaginale
Allorhizobium rosettiformansAllorhizobium rosettiformans
Kaistella senegalenseKaistella senegalense
Brevundimonas bullata
Acinetobacter idrijaensis
Haematobacter massiliensis
Paracoccus marcusii
Paracoccus aeridis
Acidovorax temperans
Microbacterium lacticum

Revision editor(s): Joiejoie, Aleru Divine